Louis Navellier’s Top Picks Killed The Market in Q1: Find Out What They Were and Why They Killed It

Anthem Inc (NYSE:ANTM) is yet another healthcare stock in Navellier’s top ten that enjoyed a strong first quarter.Navellier’s position of just under 508,000 shares landed it in ninth spot in its portfolio, representing 3.18% of its overall value. It would now account for much more all things being equal, given the 29% flight its shares took during the first quarter. Anthem Inc (NYSE:ANTM), formerly known as WellPoint Inc., is a health insurance company which has benefitted tremendously from the implementation of the U.S Affordable Care Act, which has resulted in millions of eligible new customers flooding the U.S health insurance market. Larry Robbins’ Glenview Capital was the largest shareholder of Anthem Inc (NYSE:ANTM) at the end of 2014 among the funds we follow, boasting a position of 3.59 milllion shares.

Among Navellier’s other $1 billion+ long positions which accounted for at least 2% of its portfolio value and had strong first quarter returns were Dr Pepper Snapple Group Inc. (NYSE:DPS) with 9% returns, Biogen Inc (NASDAQ:BIIB) which posted gains of 24%, Avago Technologies Ltd (NASDAQ:AVGO) which was up by 26%, Skyworks Solutions Inc. (NASDAQ:SWKS) which blew up by 35%, NXP Semiconductors NV (NASDAQ:NXPI), up by 31%, and Health Net, Inc. (NYSE:HNT), which posted returns of 13%.

Navellier & Associates is one of just 700+ hedge funds in our database at Insider Monkey, and while we follow their individual moves and top stock picks in the hopes of providing some investing insight to investors, we primarily have them in our database to track their 13F filings and their positions in small-cap stocks. That’s because we’ve found a system of imitating hedge funds’ moves that has shown the ability to regularly outperform the market, even as the hedge funds themselves have underperformed it for the past seven years running. That system is to invest in each of their collective top 15 small-cap picks, a method which over 14 years of backtesting, outperformed the market in 11 of those years. Since going live, it has continued to outperform the market each year, posting returns of 132% from the end of August 2012 when it went live, through March 11, 2015, an outperformance of the S&P 500 ETF (SPY) of 79 percentage points (see the details).

Disclosure: None